Piramal Pharma Solutions Press Releases

Press Releases

Piramal Enterprises acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

Posted on Fri, Jan 23, 2015 @ 05:10 PM by Kathy Sue Bennett in lyophilization, in parenteral manufacturing, in parenteral development, in sterile manufacturing, in antibody drug conjugates

Mumbai, 16th January, 2015: Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302) today announced that it has invested USD 30.65 million towards acquiring Coldstream Laboratories Inc. (‘Coldstream’), through its wholly owned subsidiary in the USA in an all cash transaction.  Of this, USD 5.65 million would be towards the purchase of the facility building which is currently leased to Coldstream, while the rest would be towards purchase of 100% of the company’s shares. Coldstream is a Contract Development and Manufacturing Organisation (CDMO) focused on the development and manufacturing of sterile injectable products.

0 CommentsContinue Reading →

Coldstream Laboratories Completes Successful FDA Inspection

Posted on Tue, Apr 22, 2014 @ 09:31 AM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing

LEXINGTON, KY., Apr 21, 2014 (GLOBE NEWSWIRE) --Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced the completion of a successful inspection by the Food and Drug Administration (FDA). Coldstream hosted FDA authorities from April 8 – 17, 2014, at its manufacturing facility in Lexington, KY. The site audit reviewed quality systems to ensure compliance with current Good Manufacturing Practices (cGMPs).  

0 CommentsContinue Reading →

Coldstream Laboratories Third-Time Winner of CMO Leadership Award

Posted on Fri, Apr 11, 2014 @ 09:37 AM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing

0 CommentsContinue Reading →

Coldstream Laboratories Names Director of Formulation Development

Posted on Mon, Nov 18, 2013 @ 10:56 AM by Kathy Sue Bennett in lyophilization, in parenteral manufacturing, in parenteral development, in sterile manufacturing, in product development

Adrian Raiche, Ph.D. Named as Director of Formulation Development at Coldstream Laboratories, Inc.

0 CommentsContinue Reading →

Coldstream Laboratories Awarded 5-Year Contract With the National Cancer Institute

Posted on Mon, Sep 30, 2013 @ 03:15 PM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing, in aseptic filling

LEXINGTON, KY--(Marketwired - Sep 24, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that they have been awarded a 5-year contract with the National Cancer Institute ("NCI") under solicitation number N02CM37007-11 (contract# HHSN261201300031I) entitled "Development and Production of Parenteral Dosage Forms for Clinical Studies."

0 CommentsContinue Reading →

Coldstream to Attend Generics Conference

Posted on Tue, Jul 23, 2013 @ 06:17 PM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing, in aseptic filling

Christopher A. Verbicky, Ph.D., MBA, will be attending the “6th Product and Pipeline Enhancement for Generics Conference” in this week in Washington, D.C.  The event will take place at the Sheraton Crystal City Hotel July 23 – 25, 2013.

0 CommentsContinue Reading →